Welcome and Introduction: Our Vision for the Future
Samantha Du, Ph.D., Founder, Chairperson and CEO
A Proven Model and Clear Strategy for Growth
Josh Smiley, President and Chief Operating Officer
Advancing and Expanding the Zai Oncology Pipeline
Rafael Amado, M.D., President, Head of Global Oncology Research & Development
Unmet Needs of Gastric Cancer in China
Dr. Li Jin, M.D., Ph.D., Shanghai East Hospital Affiliated with Tongji University
Tumor Treating Fields – Unmet Needs of Lung Cancer in China
Dr. Zhao Yuanyuan, M.D., Ph.D., Sun Yat-Sen University Cancer Center
Delivering and Extending the Neuroscience, Autoimmune and Infectious Diseases Pipeline
Harald Reinhart, M.D., President, Head of Global Development, Neuroscience, Autoimmune and Infectious Diseases
Unmet needs of Generalized Myasthenia Gravis
Dr. Zhao Chongbo, M.D., Ph.D., Huashan Hospital Affiliated to Fudan University
Unmet Needs of Schizophrenia in China
Dr. Wang Gang, M.D., Ph.D., Beijing Anding Hospital affiliated to Capital Medical University
Optimizing a Strong and Innovative Portfolio
William Liang, Chief Commercial Officer, President, Greater China
Strategy Focused on Growth Supported by Proven Model
Jonathan Wang, Chief Business Officer
Q&A